Arkolith/Insider Trading/UNCY/Form 4/A

Kenkare-Mitra Sara

DirectorUnicycive Therapeutics, Inc. (UNCY) · full profile →Form 4/A · filed Jun 15, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 14, 2026Grant(A)84K—$084K
May 14, 2026Grant(A)42K—$0126K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001213900-26-068921) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML